Nadolol

Product NDC: 70518-2139
11-digit product format: 705182139
Labeler code: 70518
Product ID: 70518-2139_c68899fc-090a-5f67-e053-2995a90a66fe
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Nadolol
Dosage form: TABLET
Route: ORAL
Labeler: REMEDYREPACK INC.
Application: ANDA207761
Marketing category: ANDA
Marketing start: 2019-06-10
Marketing end: 0000-00-00
Substance: NADOLOL
Active strength: 40 mg/1
Pharmacologic classes: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70518-2139-0	2023-03-08	C162847	48780-1	f386c649-de1e-0266-e053-dadaa90a7c1a	0ea8a4e6-9152-4639-b1be-133aba29f366
70518-2139-0	2023-01-30	C162847	48780-1	f386c649-de1e-0266-e053-dadaa90a7c1a	0ea8a4e6-9152-4639-b1be-133aba29f366

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
FEN504330V	NADOLOL	42200-33-9	NADOLOL

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70518-2139-0	70518213900	90 TABLET in 1 BOTTLE, PLASTIC (70518-2139-0)	90 tablet	2019-06-10	0000-00-00	No	No	Current